Tarsus Pharmaceuticals Inc (TARS)

NASDAQ HEALTHCARE
$62.09 +1.90% RSI 33 Neutral Add Alert

Moving Averages

SMA 200
$64.25
Price below

Company Profile

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$3.09B
P/E Ratio
None
EPS
$-1.59
Beta
0.63
Dividend Yield
0.00%
52-Week High
$85.25
52-Week Low
$38.51

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 3:57 PM EDT

Track TARS for free

Get e-mail RSI alerts when Tarsus Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert